LMAF
LFCR icon

Lepercq Multi-Asset Fund’s Lifecore Biomedical LFCR Stock Holding History

Lepercq Multi-Asset Fund’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$169K Buy
+22,700
New +$145K 0.12% 5

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lepercq Multi-Asset Fund's LFCR Position: Q4 2024 in Review

Lepercq Multi-Asset Fund opened a new position in Lifecore Biomedical (LFCR) in Q4 2024: 22,700 shares worth $169K. The stake represents 0.12% of the portfolio and ranks #5 among its holdings.

77 funds tracked by Wall St. Rank hold LFCR as of Q4 2024.

  • Lepercq Multi-Asset Fund held 22,700 shares of Lifecore Biomedical worth $169K as of Q4 2024.
  • Lifecore Biomedical was a new Lepercq Multi-Asset Fund position in Q4 2024.
  • Lifecore Biomedical made up 0.12% of Lepercq Multi-Asset Fund's portfolio in Q4 2024, its #5 holding.
  • 77 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2024.

Based on Lepercq Multi-Asset Fund's 13F filing for Q4 2024, filed 7 Feb 2025.